Traverse Biosciences Announces Issuance of U.S. Patent
November 18, 2015
Traverse Biosciences has announced that the U.S. Patent and Trademark Office (USPTO) has granted U.S. Patent No. 9,187,406 entitled, “Curcumin Analogues as Zinc Chelators and Their Uses,” which the company has exclusively licensed from the Research Foundation for the State University of New York (RF/SUNY). The issued patent includes claims that cover the composition of matter of the company’s proprietary library of chemically-modified curcumins, including its lead drug candidate, TRB-N0224.
Read more on the Traverse Biosciences website.